Clock.bio
PrivateLast Round
Seed
Oct 9, 2024
Total Funding Raised
$9.3M
Company Overview
Clock.bio is a biotechnology company focused on developing innovative treatments to prevent and address age-related diseases while enhancing human healthspan through stem cell research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clock.bio Comps
Public and private peers based on sector, stage, and business model.
Clock.bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 9, 2024 | ||||
| Pre Seed | Aug 31, 2023 |
Key People
Founding team and executive leadership
Clock.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LocalGlobe | Seed |
| BlueYard Capital | Seed, Pre Seed |
| Onsight Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
Dr. Michael Boehler, formerly of BioNTech, joins as CBO.
Clock.bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clock.bio's valuation, stock price, and market status.
